The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, July 14, 2025.
Professor Opuni, who previously served as the Board Chairman of the FDA, succeeds Dr. Delese Darko. Dr. Darko has held the position since 2017 and has recently assumed a new role as Director General of the Africa Medicines Agency (AMA).
In a statement issued by the Authority, it said, “The Food and Drugs Authority (FDA) is pleased to announce the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, 14th July 2025.”
The Authority expressed optimism about the future under Prof. Opuni’s leadership, stating, “The FDA extends its warmest congratulations to Prof. Opuni on his appointment and looks forward to his leadership in advancing the Authority’s mandate of safeguarding public health and safety.”
Professor Opuni is expected to bring his wealth of experience and familiarity with the FDA’s operations to bear as he leads the organization into its next chapter.
